Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C

AUTOR(ES)

Vigani, Aline Gonzalez, Pavan, Maria HP, Tozzo, Raquel, Gonçales, Eduardo SL, Lazarini, Maria SK, Oliveira, Alexandre Macedo de, Gonçales Jr, Fernando L

FONTE

Brazilian Journal of Infectious Diseases

DATA DE PUBLICAÇÃO

2010-04

RESUMO

Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.

Documentos Relacionados

• Pegylated interferon/ribavirin-associated sudden hearing loss in a patient with chronic hepatitis C in Brazil
• Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
• DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
• Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
• Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis c with pegylated interferon and ribavirin